CIK 0000014272
- Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 220790350
- Phone
- +1 609-252-4621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-10 | Weese Michelle EVP, Corporate Affairs | Grant or award · Market Share Units | +6,363 | 6,363 | ||
| 2022-03-10 | Weese Michelle EVP, Corporate Affairs | Grant or award · Performance Shares | +9,544 | 9,544 | ||
| 2022-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Option exercise | +4,189 | 15,941 | ||
| 2022-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Other acquisition | +553 | 16,494 | ||
| 2022-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Shares withheld for taxes | −2,426 | $68.42 | $166K | 14,068 |
| 2022-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Option exercise | +4,885 | 18,953 | ||
| 2022-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Other acquisition | +548 | 19,501 | ||
| 2022-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Shares withheld for taxes | −2,779 | $68.42 | $190K | 16,722 |
| 2022-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Option exercise · Market Share Units | −4,189 | 8,381 | ||
| 2022-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Option exercise · Market Share Units | −4,885 | 14,656 | ||
| 2022-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Grant or award · Market Share Units | +19,062 | 19,062 | ||
| 2022-03-10 | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Grant or award · Performance Shares | +28,593 | 28,593 | ||
| 2022-03-10 | Santiago Karen Murphy SVP & Controller | Option exercise | +683 | 15,181 | ||
| 2022-03-10 | Santiago Karen Murphy SVP & Controller | Other acquisition | +10 | 15,191 | ||
| 2022-03-10 | Santiago Karen Murphy SVP & Controller | Shares withheld for taxes | −246 | $68.42 | $17K | 14,945 |
| 2022-03-10 | Santiago Karen Murphy SVP & Controller | Option exercise | +1,156 | 16,101 | ||
| 2022-03-10 | Santiago Karen Murphy SVP & Controller | Other acquisition | +351 | 16,452 | ||
| 2022-03-10 | Santiago Karen Murphy SVP & Controller | Shares withheld for taxes | −545 | $68.42 | $37K | 15,907 |
| 2022-03-10 | Santiago Karen Murphy SVP & Controller | Option exercise | +1,141 | 17,048 | ||
| 2022-03-10 | Santiago Karen Murphy SVP & Controller | Other acquisition | +151 | 17,199 |
Page 63 of 73 · 1,445 trades